Providing WIFI Connectivity to 1M+ Customers with XNET | Rich DeVaul & Shaan Chaudhari

Follow Building in Public Podcast: https://x.com/builtnpublicpod In this episode of Building in Public, Rich and Shaan from XNET discussed their progress as a decentralized neutral host mobile operator. They explored the XIP-10 proposal to reduce token supply and its benefits for the community. Rich highlighted XNET’s demand-side GTM, enabling millions to connect via existing carriers, with growth potential in the U.S. market. They covered MNOs vs. MVNOs, international expansion, and the Solana ecosystem’s supportive culture. Updates included funding milestones, Sphere Pay and Kamino integrations, and plans to onboard millions of users to Solana, showcasing XNET’s vision for decentralized mobile networks. Timestamps: 00:00 - Introduction 00:41 - Discussion on XIP-10 and Token Burns 03:56 - Understanding XNET's Business Model 06:25 - Customer Segments: MNOs vs. MVNOs 10:09 - International Expansion and Roaming Opportunities 12:29 - Wi-Fi and Cellular Spectrum in Global Deployments 14:05 - Transition from Polygon to Solana 16:50 - Community Growth and Social Engagement 18:31 - Exciting Developments with XNET Foundation 20:49 - Meme Coins and Retail Engagement 22:31 - Scaling Supply Side through Brownfield Deployments 28:37 - Upcoming Features and Integrations 30:18 - Where to Find More Information on XNET Disclaimer: The hosts and the firms they represent may hold stakes in the companies mentioned in this podcast. None of this is financial advice.

How GenomesDAO Is Fixing Genetic Testing with Aldo de Pape

Follow Building in Public Podcast: https://x.com/builtnpublicpod In this episode, Aldo de Pape, the founder of GenomesDAO, discussed the challenges facing the genetic testing industry and how his organization is addressing them. He highlighted concerns around privacy and security, particularly in light of the increasing number of healthcare data breaches. GenomesDAO's approach prioritizes the safety and ownership of genomic data, contrasting their model with companies like 23andMe by ensuring individuals retain control over their biological samples and data via blockchain technology and partnerships with companies like AMD. Aldo also explained how GenomesDAO’s consent protocol allows individuals to be compensated for sharing their data with research partners, such as pharmaceutical companies. He discussed the value of genomic data and the ways users can engage with the platform, either by ordering a genetic testing kit or transferring data from other platforms. The episode also covered the demand side of GenomesDAO's business model, where the platform serves as secure infrastructure for genomic research, with growing interest from pharmaceutical companies. Through its focus on data ownership, security, and user empowerment, GenomesDAO is reshaping the genetic testing landscape. Timestamps: 00:00 - Introduction 00:32 - Genomic Data and Privacy Concerns 02:20 - Challenges in the Genetic Testing Industry 03:58 - GenomesDAO's Mission and Approach 04:18 - Security Measures Compared to Traditional Companies 07:39 - Monetization and Data Ownership Issues 08:27 - Consent and User Engagement 10:42 - Getting Involved with GenomesDAO 12:21 - Point System and Health Reports 18:13 - Token Launch and Blockchain Details 19:13 - Building on BASE and Ecosystem Synergies 20:58 - Demand Side and Research Partnerships 25:08 - Conclusion Disclaimer: The hosts and the firms they represent may hold stakes in the companies mentioned in this podcast. None of this is financial advice.

How GenomesDAO Is Fixing Genetic Testing with Aldo de Pape

Follow Building in Public Podcast: https://x.com/builtnpublicpod In this episode, Aldo de Pape, the founder of GenomesDAO, discussed the challenges facing the genetic testing industry and how his organization is addressing them. He highlighted concerns around privacy and security, particularly in light of the increasing number of healthcare data breaches. GenomesDAO's approach prioritizes the safety and ownership of genomic data, contrasting their model with companies like 23andMe by ensuring individuals retain control over their biological samples and data via blockchain technology and partnerships with companies like AMD. Aldo also explained how GenomesDAO’s consent protocol allows individuals to be compensated for sharing their data with research partners, such as pharmaceutical companies. He discussed the value of genomic data and the ways users can engage with the platform, either by ordering a genetic testing kit or transferring data from other platforms. The episode also covered the demand side of GenomesDAO's business model, where the platform serves as secure infrastructure for genomic research, with growing interest from pharmaceutical companies. Through its focus on data ownership, security, and user empowerment, GenomesDAO is reshaping the genetic testing landscape. Timestamps: 00:00 - Introduction 00:32 - Genomic Data and Privacy Concerns 02:20 - Challenges in the Genetic Testing Industry 03:58 - GenomesDAO's Mission and Approach 04:18 - Security Measures Compared to Traditional Companies 07:39 - Monetization and Data Ownership Issues 08:27 - Consent and User Engagement 10:42 - Getting Involved with GenomesDAO 12:21 - Point System and Health Reports 18:13 - Token Launch and Blockchain Details 19:13 - Building on BASE and Ecosystem Synergies 20:58 - Demand Side and Research Partnerships 25:08 - Conclusion Disclaimer: The hosts and the firms they represent may hold stakes in the companies mentioned in this podcast. None of this is financial advice.

How GenomesDAO Is Fixing Genetic Testing with Aldo de Pape

Follow Building in Public Podcast: https://x.com/builtnpublicpod In this episode, Aldo de Pape, the founder of GenomesDAO, discussed the challenges facing the genetic testing industry and how his organization is addressing them. He highlighted concerns around privacy and security, particularly in light of the increasing number of healthcare data breaches. GenomesDAO's approach prioritizes the safety and ownership of genomic data, contrasting their model with companies like 23andMe by ensuring individuals retain control over their biological samples and data via blockchain technology and partnerships with companies like AMD. Aldo also explained how GenomesDAO’s consent protocol allows individuals to be compensated for sharing their data with research partners, such as pharmaceutical companies. He discussed the value of genomic data and the ways users can engage with the platform, either by ordering a genetic testing kit or transferring data from other platforms. The episode also covered the demand side of GenomesDAO's business model, where the platform serves as secure infrastructure for genomic research, with growing interest from pharmaceutical companies. Through its focus on data ownership, security, and user empowerment, GenomesDAO is reshaping the genetic testing landscape. Timestamps: 00:00 - Introduction 00:32 - Genomic Data and Privacy Concerns 02:20 - Challenges in the Genetic Testing Industry 03:58 - GenomesDAO's Mission and Approach 04:18 - Security Measures Compared to Traditional Companies 07:39 - Monetization and Data Ownership Issues 08:27 - Consent and User Engagement 10:42 - Getting Involved with GenomesDAO 12:21 - Point System and Health Reports 18:13 - Token Launch and Blockchain Details 19:13 - Building on BASE and Ecosystem Synergies 20:58 - Demand Side and Research Partnerships 25:08 - Conclusion Disclaimer: The hosts and the firms they represent may hold stakes in the companies mentioned in this podcast. None of this is financial advice.